← Current compounder rows

Current NDC auxiliary source row compounder:2776

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
26436-5482
Product Ndc
26436-5482
Product Ndc Digits
264365482
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
ACS
Proprietary Name Suffix
[empty]
Nonproprietary Name
Ampotericin/ Chloramphenicol/ Sulfamethoxazole
Dosage Form Name
POWDER
Route Name
AURICULAR (OTIC)
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Hybrid Pharma
Establishment Name
Hybrid Pharma
Establishment Fei
[empty]
Substance Name
AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL
Active Ingredients Info
60 mg/1 g; 470 mg/1 g; 470 mg/1 g
History Active Ingredients Raw
AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL
History Active Ingredients Info Raw
60 mg/1 g; 470 mg/1 g; 470 mg/1 g
History Dosage Raw
POWDER
Dea Schedule
[empty]
Package Ndc Raw
26436-5482-1
Package Ndc
26436-5482-1
Package Ndc Digits
2643654821
Package Ndc11
26436548201
Package Description
10 g in 1 JAR (26436-5482-1)
Reporting Period Raw
2026-1
Reporting Period
2026-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:2776
Source Row Number
2776
Source Row Hash
be8bfd90ae686eb1f27ee34ca2fc9f99fa2e819462aa7bb25002704e837965e8
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "AURICULAR (OTIC)",
    "PRODUCTNDC": "26436-5482",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL",
    "DOSAGEFORMNAME": "POWDER",
    "NDCPACKAGECODE": "26436-5482-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "ACS",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Ampotericin/ Chloramphenicol/ Sulfamethoxazole",
    "PACKAGEDESCRIPTION": "10 g in 1 JAR (26436-5482-1) ",
    "ACTIVEINGREDIENTSINFO": "60 mg/1 g; 470 mg/1 g; 470 mg/1 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:2776
Source Row Number
2776
Status Scope
package
Lookup Ndc
26436-5482-1
Lookup Ndc Digits
2643654821
Product Ndc
26436-5482
Product Ndc Digits
264365482
Package Ndc
26436-5482-1
Package Ndc Digits
2643654821
Package Ndc11
26436548201
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2026-1
Reporting Period
2026-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
be8bfd90ae686eb1f27ee34ca2fc9f99fa2e819462aa7bb25002704e837965e8
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00